KYNTRA BIO, INC. Operating Lease Right-of-Use Assets
KYNTRA BIO, INC. (KYNB) had Operating Lease Right-of-Use Assets of $0 as of 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-03-17
- 2024-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2024-09-30: Operating Lease, Right-of-Use Asset $2.09M.
- 2024-06-30: Operating Lease, Right-of-Use Asset $61.21M.
- 2024-03-31: Operating Lease, Right-of-Use Asset $64.75M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-17 | |
| 2024-09-30 | $2.09M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $61.21M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $64.75M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $64.94M 10-K · filed 2025-03-17 | $68.09M 10-K · filed 2024-02-26 |
| 2023-09-30 | $71.25M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $74.40M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $76.67M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $79.89M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $82.90M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $84.65M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $87.99M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $91.11M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $94.06M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $97.09M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $5.08M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $2.04M 10-K/A · filed 2022-03-04 | |
| 2020-09-30 | $1.24M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.38M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.66M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.93M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $2.19M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $939.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $608.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |